EDN1 and ischemia: In CMD, structural remodelling including reduction in capillary diameter, fibrosis, and capillary rarefaction [123], alongside functional endothelial dysregulation such as impaired nitric oxide [13] endothelin-1 (ET-1) related vasodilatory capacity [117] elevates resistance to the point of inhibiting flow, causing ischemia.